| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 01/17/2002 | DE10031955A1 Curcumin-Derivate mit gegenüber Curcumin verbesserter Wasserlöslichkeit und diese enthaltende Arzneimittel Curcumin derivatives with respect to curcumin improved water solubility and pharmaceutical compositions containing them |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171153A2 Novel medical use of alpha-1-acidic glycoprotein (aag) or orosomucoid |
| 01/16/2002 | EP1171143A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 01/16/2002 | EP1171081A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | CN1331606A Oil-in-water emulsion exhibiting protective action against damages to human organs resulting from peroxidation and prodn. and use thereof |
| 01/16/2002 | CN1077773C Heatstroke preventing tea |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001043697A3 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169316A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169062A2 Heat stable coated colloidal iron oxides |
| 01/09/2002 | EP1169005A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 01/09/2002 | CN1077406C Arctium lappa tea |
| 01/09/2002 | CN1077405C Antidotal health tea and processing method thereof |
| 01/09/2002 | CN1077404C Health-care tea and its production method |
| 01/08/2002 | CA2150703C Substituted pyrazoles |
| 01/03/2002 | WO2002102789A1 Antimicrobial and radioprotective compounds |
| 01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
| 01/03/2002 | WO2002000645A1 Indole derivatives useful for the treatment of cns disorders |
| 01/03/2002 | WO2002000260A1 Remedial agent for optic nerve disease and the like |
| 01/03/2002 | WO2002000238A1 Compositions promoting alcohol metabolism |
| 01/03/2002 | WO2002000217A1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 01/03/2002 | WO2002000190A1 Cosmetic and pharmaceutical compositions and methods using green-light emitting materials |
| 01/03/2002 | WO2002000167A2 Modified forms of pharmacologically active agents and uses therefor |
| 01/03/2002 | WO2001051473A8 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
| 01/03/2002 | US20020002296 Cytoprotective Compounds |
| 01/03/2002 | US20020002203 Administering an effective amount of a compound selected from aryl(and heterocyclic) ureido and aryl(heterocyclic) carboxamido phenoxyisobutyric acids as inhibitor of glycation and advanced glycation endproducts (AGEs) (protein-aging) |
| 01/03/2002 | US20020002161 5-HT ligands used to treat central nervous system disorders |
| 01/03/2002 | US20020002145 Adenosine A2A receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/03/2002 | CA2414115A1 Indole derivatives useful for the treatment of cns disorders |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/02/2002 | EP1165596A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 01/02/2002 | EP1165537A1 Hydroxymatairesinol in cancer prevention |
| 01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 01/02/2002 | EP1165092A1 Cyclopentanone derivatives and their use |
| 01/02/2002 | EP1165079A2 Improved dialysis solutions and methods |
| 01/02/2002 | EP1164874A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions |
| 01/02/2002 | CN1328845A Chinese medicine preparation for curing metals poisoning |
| 01/01/2002 | US6335328 Process for the isolation of galanthamine |
| 01/01/2002 | US6335023 Vehicles and oligosaccharide aldonic acids |
| 12/27/2001 | WO2001098481A2 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | WO2001098461A1 Micro-organisms active in the digestive environment |
| 12/27/2001 | WO2001098332A2 Secreted redox proteins |
| 12/27/2001 | WO2001098289A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | WO2001097820A2 Kefir as a potent anti-oxidant composition |
| 12/27/2001 | WO2001097806A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/27/2001 | WO2001097793A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| 12/27/2001 | WO2001070254A9 Use of human not1 and not1a orphan receptors |
| 12/27/2001 | WO2001062223A3 Cosmetic preparations containing plant extracts |
| 12/27/2001 | WO2001060349B1 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 12/27/2001 | US20010056108 Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutical administration of nitric oxide sources |
| 12/27/2001 | CA2417687A1 Kefir as a potent anti-oxidant composition |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413526A1 Micro-organisms active in the digestive environment |
| 12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | CA2412362A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/26/2001 | CN1328461A Method for preventing/treating damage to sensory hair cells and cochlear neurons |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096345A1 Tetrapyrroles |
| 12/20/2001 | WO2001096322A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | WO2001096289A1 Sulfonamide derivatives |
| 12/20/2001 | WO2001095937A2 Phytoestrogenic isoflavone compositions |
| 12/20/2001 | WO2001095932A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 12/20/2001 | WO2001015693A3 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 12/20/2001 | CA2412623A1 Tetrapyrroles |
| 12/20/2001 | CA2411811A1 Sulfonamide derivatives |
| 12/20/2001 | CA2410824A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor |
| 12/19/2001 | EP1163231A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics |
| 12/19/2001 | EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 12/19/2001 | EP1162981A1 Treatment of accidental extravasation of anthracyclines |
| 12/19/2001 | EP0980349B1 Process for producing conjugated linolenic acid-based synthetic triglycerides |
| 12/19/2001 | EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 12/19/2001 | CN1076174C Dongling (Rabdosia rubescens) coffee and its preparation method |
| 12/19/2001 | CN1076173C Body-perfuming tea preparation |
| 12/18/2001 | US6331520 Luteinizing hormone releasing hormone peptide agonist or antagonist; or growth hormone releasing factor peptide; nicontinamide aqueous solution |
| 12/18/2001 | CA2202484C Use of indole derivatives for the treatment of various diseases |
| 12/13/2001 | WO2001094381A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 12/13/2001 | WO2001093885A1 Therapeutic agents - ii |
| 12/13/2001 | WO2001093884A1 Therapeutic agents - i |
| 12/13/2001 | WO2001093883A1 Therapeutic agents - iii |
| 12/13/2001 | WO2001093867A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | CA2411596A1 Therapeutic agents - ii |